Items: 0 Total: $0.00 Cart

Celiac Disease Foundation Attends FDA Patient-Focused Drug Development Workshop

Posted on June 4, 2015

CDFIn May, CDF CEO Marilyn G. Geller represented the celiac community at the public meeting of the U.S. Food and Drug Administration Functional GI Patient-Focused Drug Development Conference (PFDD) at FDA headquarters just outside of Washington, D.C.

According to the CDF, the PFDD process, including the results from patient surveys, helps the FDA understand first-hand, independent of the opinions of their staff and the pharmaceutical companies, what types of treatments patients desire to improve their quality of life, especially if the disease is chronic, as celiac disease is.

See Full Article

Category: News

Leave a Reply